Pas­cal So­ri­ot bud­gets a fi­nal £100M to fin­ish As­traZeneca's new HQ — now 9 years and £1B-plus in the mak­ing

What’s an­oth­er £100 mil­lion when you’ve al­ready gone three times over bud­get?

Just an­oth­er round­ing num­ber for As­traZeneca, which is still run­ning up the tab on its gleam­ing new R&D/HQ in Cam­bridge, UK.

The Times spot­light­ed the fresh out­lay in­clud­ed in the phar­ma gi­ant’s an­nu­al re­port, with a re­minder of the ini­tial bud­get and com­ple­tion date — £330 mil­lion in 2016. But As­traZeneca is reach­ing deep­er now to pay for lab equip­ment, fur­ni­ture and oth­er fin­ish-outs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER